Investments in Taiwan's biotechnology-related industry is expected to grow 15 percent to NT$25 billion this year, the Ministry of Economic Affairs said yesterday.
The growth is in line with the Cabinet's plan to attract a total of NT$100 billion investment in biotech between 2002 and 2007 and to double production output to NT$250 billion.
"Investment was boosted by a total of 91 new local and foreign investors in biotechnological medicine, medical equipment, agricultural technology, cosmetics and nanotechnology," Wang Shu-hui, (
According to Wang, the investment for the first 10 months of this year already climbed to NT$23.49 billion from NT$19.42 billion a year earlier.
Wang attributed the rapid growth to the establishment of several large biotechnology funds, including a NT$2.5 billion investment raised by a joint venture fund between China Development Financial Holding Corp (中華開發金控) and the Cabinet's Development Fund (開發基金). Another fund, Fortune Athena Biotech Fund (瑞銀生化基金), brought in NT$1.4 billion.
Other small and medium-sized investments, including NT$1 billion from ScinoPharm Taiwan Ltd (台灣神隆) and NT$1 billion from state-run Taiwan Sugar Corp (Taisugar, 台糖), were made in the fields of medical research as well as cosmetics.
Several US biotech companies including Epicyte Pharmaceutical Inc, Genemed Biotechnologies Inc, Ancile Pharmaceuticals Inc and Corgentech Inc, have poured NT$3.07 billion into Taiwan's biotech industry in the last few years, according to Industrial Development Bureau.
Despite reportedly high growth in the sector, several pundits warned of serious hurdles blocking the road to Taiwan's biotech development.
The biggest problem, said John Yang (
Taisugar, a state-run enterprise, is allocating NT$20 million each year cooperative projects with Academia Sinica and the Biomedical Engineering Center at the Industrial Technology Research Institute (工研院).
"We are having difficulty transferring [their] innovations into concrete product ideas," he said.
Biologists have begun to encourage local biotech professionals to pool their findings with foreign firms to keep ahead of the technology race.
Chen Yih-ming (
Kuo Shu-shyang (郭書祥), professor of the Development Center for Biotechnology (生物技術開 發中心), said that Taiwan's burgeoning biotech businesses are already lagging behind other countries and only by cooperating with other international businesses can they skip the "learning phrase."
SEASONAL WEAKNESS: The combined revenue of the top 10 foundries fell 5.4%, but rush orders and China’s subsidies partially offset slowing demand Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) further solidified its dominance in the global wafer foundry business in the first quarter of this year, remaining far ahead of its closest rival, Samsung Electronics Co, TrendForce Corp (集邦科技) said yesterday. TSMC posted US$25.52 billion in sales in the January-to-March period, down 5 percent from the previous quarter, but its market share rose from 67.1 percent the previous quarter to 67.6 percent, TrendForce said in a report. While smartphone-related wafer shipments declined in the first quarter due to seasonal factors, solid demand for artificial intelligence (AI) and high-performance computing (HPC) devices and urgent TV-related orders
BYPASSING CHINA TARIFFS: In the first five months of this year, Foxconn sent US$4.4bn of iPhones to the US from India, compared with US$3.7bn in the whole of last year Nearly all the iPhones exported by Foxconn Technology Group (富士康科技集團) from India went to the US between March and last month, customs data showed, far above last year’s average of 50 percent and a clear sign of Apple Inc’s efforts to bypass high US tariffs imposed on China. The numbers, being reported by Reuters for the first time, show that Apple has realigned its India exports to almost exclusively serve the US market, when previously the devices were more widely distributed to nations including the Netherlands and the Czech Republic. During March to last month, Foxconn, known as Hon Hai Precision Industry
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) and the University of Tokyo (UTokyo) yesterday announced the launch of the TSMC-UTokyo Lab to promote advanced semiconductor research, education and talent development. The lab is TSMC’s first laboratory collaboration with a university outside Taiwan, the company said in a statement. The lab would leverage “the extensive knowledge, experience, and creativity” of both institutions, the company said. It is located in the Asano Section of UTokyo’s Hongo, Tokyo, campus and would be managed by UTokyo faculty, guided by directors from UTokyo and TSMC, the company said. TSMC began working with UTokyo in 2019, resulting in 21 research projects,
Quanta Computer Inc (廣達) chairman Barry Lam (林百里) yesterday expressed a downbeat view about the prospects of humanoid robots, given high manufacturing costs and a lack of target customers. Despite rising demand and high expectations for humanoid robots, high research-and-development costs and uncertain profitability remain major concerns, Lam told reporters following the company’s annual shareholders’ meeting in Taoyuan. “Since it seems a bit unworthy to use such high-cost robots to do household chores, I believe robots designed for specific purposes would be more valuable and present a better business opportunity,” Lam said Instead of investing in humanoid robots, Quanta has opted to invest
RSS